Patents by Inventor Matthew J Evans

Matthew J Evans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240149054
    Abstract: A system for stimulating body tissue may include a user interface and a control unit. The control unit may include a processor and non-transitory computer readable medium. The non-transitory computer readable medium may store instructions that, when executed by the processor, causes the processor to identify an electrode combination and determine a threshold charge for use in stimulating the body tissue. The processors identifications and determinations may be based at least partially on input received via the user interface.
    Type: Application
    Filed: January 5, 2024
    Publication date: May 9, 2024
    Applicant: Lungpacer Medical Inc.
    Inventors: Matthew J. GANI, Kaitlin TAYLOR, Viral S. THAKKAR, Douglas G. EVANS
  • Patent number: 8703149
    Abstract: The invention relates to the discovery that the Claudin-1 protein functions as a co-receptor for entry of HCV into cells. Methods of inhibiting, preventing or mitigating HCV infections by inhibiting HCV interactions with Claudin-1 are provided. Methods of identifying agents or compounds that interfere with HCV interactions with Claudin-1 are also provided. Finally, useful kits, cell culture compositions, agents, and compounds related to the inhibition of HCV interactions with Claudin-1 are also disclosed.
    Type: Grant
    Filed: August 23, 2011
    Date of Patent: April 22, 2014
    Assignee: The Rockefeller University
    Inventors: Charles Rice, Matthew J. Evans, Thomas Von Hahn
  • Publication number: 20120054879
    Abstract: The invention relates to the discovery that the Claudin-1 protein functions as a co-receptor for entry of HCV into cells. Methods of inhibiting, preventing or mitigating HCV infections by inhibiting HCV interactions with Claudin-1 are provided. Methods of identifying agents or compounds that interfere with HCV interactions with Claudin-1 are also provided. Finally, useful kits, cell culture compositions, agents, and compounds related to the inhibition of HCV interactions with Claudin-1 are also disclosed.
    Type: Application
    Filed: August 23, 2011
    Publication date: March 1, 2012
    Applicant: THE ROCKEFELLER UNIVERSITY
    Inventors: Charles Rice, Matthew J. Evans, Thomas Von Hahn
  • Patent number: 8021835
    Abstract: The invention relates to the discovery that the Claudin-1 protein functions as a co-receptor for entry of HCV into cells. Methods of inhibiting, preventing or mitigating HCV infections by inhibiting HCV interactions with Claudin-1 are provided. Methods of identifying agents or compounds that interfere with HCV interactions with Claudin-1 are also provided. Finally, useful kits, cell culture compositions, agents, and compounds related to the inhibition of HCV interactions with Claudin-1 are also disclosed.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: September 20, 2011
    Assignee: The Rockefeller University
    Inventors: Charles Rice, Matthew J. Evans, Thomas Von Hahn
  • Publication number: 20100062419
    Abstract: The present invention provides infectious recombinant Hepatitis C Viruses (HCV), and vectors, cells and animals comprising the same. The present invention provides methods of producing infectious recombinant HCV, and their use in identifying anti-HCV therapeutic agents, as well as sequences of HCV associated with HCV pathogenesis.
    Type: Application
    Filed: October 19, 2009
    Publication date: March 11, 2010
    Applicant: THE ROCKEFELLER UNIVERSITY
    Inventors: Charles Rice, Matthew J. Evans, Brett D. Lindenbach, Christopher Jones
  • Patent number: 7674612
    Abstract: The present invention provides infectious recombinant Hepatitis C Viruses (HCV), and vectors, cells and animals comprising the same. The present invention provides methods of producing infectious recombinant HCV, and their use in identifying anti-HCV therapeutic agents, as well as sequences of HCV associated with HCV pathogenesis.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: March 9, 2010
    Assignee: The Rockefeller University
    Inventors: Charles Rice, Brett D Lindenbach, Matthew J Evans, Christopher Jones
  • Publication number: 20090098123
    Abstract: The invention relates to the discovery that the Claudin-1 protein functions as a co-receptor for entry of HCV into cells. Methods of inhibiting, preventing or mitigating HCV infections by inhibiting HCV interactions with Claudin-1 are provided. Methods of identifying agents or compounds that interfere with HCV interactions with Claudin-1 are also provided. Finally, useful kits, cell culture compositions, agents, and compounds related to the inhibition of HCV interactions with Claudin-1 are also disclosed.
    Type: Application
    Filed: May 4, 2007
    Publication date: April 16, 2009
    Applicant: The Rockefeller University
    Inventors: Charles Rice, Matthew J. Evans, Thomas Von Hahn
  • Patent number: 5715868
    Abstract: A single-piece tube 20 is formed to include a hub 30 at first end 26 of the tube with a spout 44 extending from the hub to a second 28 of the tube. A tapered transition surface 38 extends between the hub 30 and the spout 44. A bevel 34 is formed at the base of the hub 30 on an outer surface 22 thereof adjacent the end 26 of the tube 20. An annular bead 36 is formed on the outer surface 22 of the hub 30 at a location spaced from the bevel 34 to define a space 46 between the bevel and the bead. A pair of bends 40 and 42 are formed in spaced portions of the spout 44. In another embodiment, an annular groove 50 is formed in the outer surface 22 of the hub 30 instead of the bevel 34 and the bead 36. An O-ring 48 can be located in the space 46 or the groove 50. The single-piece tube 20 formed with the hub 30 and the spout 44 can be assembled with a water mixing facility 56.
    Type: Grant
    Filed: February 26, 1997
    Date of Patent: February 10, 1998
    Assignee: Emhart Inc.
    Inventors: Fred Y. F. Ching, Matthew J. Evans, Christopher G. Gurr